ResearcherVall d'Hebron Hospital UniversitariActive in the last 2 years
Ana P. Vivancos
Matched on ORCID iD 0000-0003-2888-6512; OpenAlex author ID A5071876778. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 6
- Utility of archived EUS-guided fine-needle biopsy samples for next-generation sequencing in pancreatic adenocarcinoma. Co-author DOI 10.1097/eus.0000000000000197↗
- A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer. Co-author DOI 10.1016/j.clcc.2024.05.002↗
- Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis. Last author DOI 10.1016/j.ctrv.2023.102604↗
- Clinical and genomic characterisation of early-onset pancreatic cancer. Co-author DOI 10.1016/j.ejca.2023.113338↗
- Clinical and genomic characterization of pancreatic ductal adenocarcinoma patients with lung oligometastasis. Co-author DOI 10.1016/j.esmogo.2023.08.010↗
- Pancreatic cancer heterogeneity and response to Mek inhibition. Co-author DOI 10.1038/onc.2017.174↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Teresa Mercade Macarulla · 5 shared papers, 2017–2026 · strength 0.79
- Paper Utility of archived EUS-guided fine-needle biopsy samples for next-generation sequencing in pancreatic adenocarcinoma. DOI 10.1097/eus.0000000000000197↗
- Paper Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review … DOI 10.1016/j.ctrv.2023.102604↗
- Paper Clinical and genomic characterisation of early-onset pancreatic cancer. DOI 10.1016/j.ejca.2023.113338↗
- Florian Castet · 4 shared papers, 2023–2026 · strength 0.73
- Paper Utility of archived EUS-guided fine-needle biopsy samples for next-generation sequencing in pancreatic adenocarcinoma. DOI 10.1097/eus.0000000000000197↗
- Paper Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review … DOI 10.1016/j.ctrv.2023.102604↗
- Paper Clinical and genomic characterisation of early-onset pancreatic cancer. DOI 10.1016/j.ejca.2023.113338↗
- Elizabeth Pando Rau · 2 shared papers, 2023–2026 · strength 0.41
- Paper Utility of archived EUS-guided fine-needle biopsy samples for next-generation sequencing in pancreatic adenocarcinoma. DOI 10.1097/eus.0000000000000197↗
- Paper Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review … DOI 10.1016/j.ctrv.2023.102604↗
- Rodrigo Mata Mata · 1 shared paper, 2026 · strength 0.24
- María Teresa Salcedo Allende · 1 shared paper, 2026 · strength 0.24
- Piero Alberti · 1 shared paper, 2026 · strength 0.24
- Josep M. Tabernero · 2 shared papers, 2017–2023 · strength 0.22
- Ramón Charco Torra · 1 shared paper, 2023 · strength 0.18
- Laura Vidal · 1 shared paper, 2023 · strength 0.18
- María Vila-Casadesús · 1 shared paper, 2024 · strength 0.16
- Alberto Hernando‐Calvo · 1 shared paper, 2024 · strength 0.16
- Aaron Richard Hansen · 1 shared paper, 2024 · strength 0.16
- Benjamin Haibe‐Kains · 1 shared paper, 2024 · strength 0.16
- Lillian Siu · 1 shared paper, 2024 · strength 0.16
- Philippe Lucien Bedard · 1 shared paper, 2024 · strength 0.16
- Anthony Turpin · 1 shared paper, 2023 · strength 0.15
- Natalia Soledad Tissera · 1 shared paper, 2023 · strength 0.15
- Marta Chiaravalli · 1 shared paper, 2023 · strength 0.15
- Giampaolo Tortora · 1 shared paper, 2023 · strength 0.15
- Pascal R. Hammel · 1 shared paper, 2023 · strength 0.15
- Kim Pedersen · 1 shared paper, 2017 · strength 0.06
- Faiz Bilal Espejo · 1 shared paper, 2017 · strength 0.06
- Irit Sagi · 1 shared paper, 2017 · strength 0.06
- Vishnu Mohan · 1 shared paper, 2017 · strength 0.06
- Daniel Massó-Vallés · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.